Clinical efficacy and safety of a single administration of fluralaner injectable suspension (BRAVECTO® injectable) vs. monthly administration of oral afoxolaner (NexGard®) in dogs for tick and flea control over one year under European field conditions

Abstract Background Year-round control of canine flea and tick infestations requires owner compliance with recommendations for regular treatments. Compliance failures can result in increased exposure of dogs to tick-borne pathogens and resurgence of flea populations. This study investigated the year...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Ivo Petersen, Susanne Goebel-Lauth, Thierry Pobel, Maria J. Gil, Wolfgang Löhlein, Oliver Wolf, Eva Zschiesche, Bjoern Welzel, Lea Heinau
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2024-12-01
Sarja:	Parasites & Vectors
Aiheet:	Afoxolaner Bravecto® injectable Dog Flea Ticks Fluralaner
Linkit:	https://doi.org/10.1186/s13071-024-06590-1
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!